Research & Analysis

India’s Vaccine Maitri with Africa

The COVID-19 pandemic outbreak has left a mark on countries across the world. Africa is no different with the virus impacting countries across the region. African countries launched a robust response to deal with the pandemic. As a result, Africa has fared significantly better than other parts of the world, a year after the outbreak.1

India shares a close partnership with African countries. In recent years, India has visibly enhanced the level of political and economic engagement with the region. Amidst the current pandemic, India has continued its diplomatic engagement with the region. The Vaccine Maitri (Friendship) initiative, launched by the Indian government, provides fresh opportunity for furthering cooperation with Africa, particularly in the health sector, which has been a crucial part of India’s partnership with Africa.

India-Africa Health Cooperation

The India-Africa development cooperation in health sector has gained greater salience in view of the several global and regional health policy instruments. Prominent amongst them are the 2030 Agenda for Sustainable Development, including the Sustainable Development Goals (SDGs) and ‘Agenda 2063: The Africa We Want’, launched by the African Union.2 These instruments call for ensuring healthy lives and promoting wellbeing for all. India’s national health policy also echoes these goals.

Over the years, India, well known as the pharmacy of the world, has provided low cost, generic drugs to several African countries to combat HIV/AIDS, TB, Malaria and other infectious diseases. The Indian firm Cipla, has supplied anti-retroviral medicines for HIV/AIDS treatment to African countries at a minimal cost. Its Dollar-a-Day treatment programme has helped several African countries. Similarly, pharmaceutical firm Ranbaxy Laboratories has been very active in Africa for decades.3

Another  important initiative,  the Pan-African e-Network, first launched in 2009 and relaunched as the eVidya Bharti e Arogya Bharti (eVBAB) project in 2019, has connected hospitals in 54 African countries with medical practitioners in India to provide consultations and comprehensive tele-medicine training opportunities for African doctors, nurses and paramedics.

Covid-19 Pandemic

Africa has around 3.9 million confirmed COVID 19 cases, as of March 11, 2021.4 Maximum cases have been reported in South Africa (1.5 million) followed by Morocco, Tunisia, Algeria, Nigeria and Kenya. From the outset, India maintained contact with countries in the region, and exchanged information on the management of the pandemic.5

With a population of around 1.3 billion, India is facing a major battle of its own fighting COVID-19.  However, the country has demonstrated capacity to support its partner countries. Since the coronavirus pandemic began, India has been at the forefront of supplying medicines and generic drugs to others.

India supplied hydroxychloroquine and paracetamol tablets, test kits, and other medical equipment for about 90 countries, including 25 from Africa.6 India has also helped with capacity building by offering health care training for COVID-19 management and protocols to several countries in Africa through the e-ITEC courses.

India’s defence forces have played a key role in implementing the country’s health cooperation initiatives with the African continent. Under Mission Sagar initiative, the Indian Naval Ship, INS Kesari, supplied COVID-related relief to Mauritius, the Seychelles, Madagascar and the Comoros. Similarly under Mission ‘Sagar-II’, Indian Naval Ship, Airavat, sailed to Sudan, South Sudan, Djibouti and Eritrea with medicines and material to support their fight against natural calamities and COVID-19 pandemic.7

Such missions are aligned with Prime Minister Narendra Modi’s vision of SAGAR — Security and Growth for All in the Region. They highlight the importance accorded by India to relations with its maritime neighbours, including those in Africa. These early responses during the pandemic have been buttressed by the Indian drive to share the Made-in-India vaccines across the world.

Vaccine Maitri Initiative

The inequity in the access and distribution of the Covid vaccine has left the African countries and India equally aghast. Rwandan President Paul Kagame has warned that vaccine nationalism “could undermine decades of progress in human development, while investing in vaccination for all would benefit international trade in the near future”.8 President Cyril Ramaphosa of South Africa has also drawn attention to the problem of vaccine hoarding by developed countries.9

India has constantly raised its voice against vaccine nationalism and has supported initiatives calling for international cooperation to ensure global access to the vaccine.10 At a time, when rich and powerful countries are resorting to vaccine nationalism, India launched the Vaccine Maitri initiative. This initiative marks the supply of Made-in-India COVID vaccine for free or at a marginal cost to countries around the world. The leading Made-in-India vaccines are Covaxin, manufactured by Bharat Biotech and the Oxford-AstraZeneca Covishield, produced by the Serum Institute of India.

The Vaccine Maitri Initiative has been launched in line with India’s philosophy of ‘Vasudhaiva Kutumbakam’ (the world is one family), as flagged by Prime Minister Modi during the Vaccine Summit in June 2020.11 As the largest vaccine producing country in the world, India has gifted millions of doses of the COVID vaccine to countries across the world, including in Africa. 

Seychelles was the first African country to receive the Indian made vaccines. During the handing over ceremony, Sylvestre Radegonde, Minister for Foreign Affairs and Tourism of Seychelles, noted that this “gesture cements the ties of solidarity, friendship and cooperation which exists between our two countries.”12

Similar sentiments were echoed by other African countries that received the vaccines, including Algeria, Angola, Botswana, Egypt, Ethiopia, Ghana, Kenya, Lesotho, Liberia, Malawi, Mali, Mauritius, Morocco, Mozambique, Nigeria, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, the Democratic Republic of Congo, and Uganda.

As India rolls out its pandemic diplomacy with African countries, an important challenge is from criminal networks that may either hijack the consignments or supply fake vaccines. South African police recently busted a fake Covid-19 vaccine distribution network.13 Three Chinese nationals were arrested in this incident. In past, China has been involved in supplying fake medicines under the Made-in-India tag to African countries.14

In recent years, China’s footprint has also been rising in the African continent. This is visible in the increase in bilateral trade along with investments in large infrastructure projects in several African countries. During the pandemic, China has pledged to supply Sinopharm vaccines to around 20 African countries.

India’s Vaccine Maitri initiative will no doubt help African countries in the fight against the pandemic and foster stronger ties based on the principle of South-South cooperation.

 

Support Ethical Journalism. Support The Dispatch

The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism


 

The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies   

About the author

Ruchita Beri | MP-IDSA

Senior Research Associate at the Manohar Parrikar Institute for Defence Studies and Analysis, New Delhi

Add Comment

Click here to post a comment